Clinical Trials Directory

Trials / Completed

CompletedNCT04717063

Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2

Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination Phase 2

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Colgate Palmolive · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

To evaluate the antibacterial efficacy of a commercial mouthwash containing 1.5% hydrogen peroxide in reducing the levels of bacteria in bioaerosols generated by dental prophylaxis.

Detailed description

Following a washout period, subjects will return to the clinical site. A baseline microbial sample will be collected from the operatory's atmosphere for 30 min. prior to the study subject appointment by placing blood agar plates on a support board attached to the bracket chair tray. Upon completion of a half-mouth (e.g. right side) dental prophylaxis, each study subject will be instructed to rinse for one minute with 10 ml of one of the two mouthwash solutions (1.5% hydrogen peroxide or 0.0% hydrogen peroxide) and to expectorate all remaining liquid. Next, the dental prophylaxis will be completed on the other side of the mouth. Bioaerosol samples will be collected prior to and following rinsing on blood agar plates placed on a support board at a 50-degree angle to the participant's chest, on the participant's chest, and on the examiner's forehead. Plates will be closed and labeled. The plates will be transferred to the microbiology laboratory for analysis. All subjects will be followed for adverse events throughout the study.

Conditions

Interventions

TypeNameDescription
DRUGPeroxyl Oral Productmouth wash
DRUGPlaceboplacebo mouth wash

Timeline

Start date
2020-11-16
Primary completion
2020-12-30
Completion
2021-01-07
First posted
2021-01-20
Last updated
2021-01-20

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04717063. Inclusion in this directory is not an endorsement.